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ISSUES IN MEDICINE
PREVE TING TRANSMISSION OF
HIV FROM MOTHER TO CHILD -
IS SOUTH AFRICA READY AND
WILLING?
David Wilkinson, James Mclntyre
From a purely epidemiological perspective the transmission of
HN from a mother to her child (MTCT) is irrelevant, as most
infected children die before being able to transmit the virus
further. MTCT is therefore effectively a dead-end for
transmission. Of course as public health practitioners this does
not concern us, as we are charged with protecting the health of
all, and the lives of children are especiaUy valued.
Over the past decade, a wide range of studies in developed
and developing countries have demonstrated MTCT of HIV,
and that it occurs in between 20% and 40% of HN-infected
pregnant woman, depending on setting.' The risk factors for
and timing of transmission have been defined, and more
recently effective interventions have been developed. In 1994
the landmark ACTG 076 trial done in the USA and France'
showed that a lengthy, complex and expensive regimen of
zidovudine (ZDV) given through pregnancy, in labour and to
the newborn reduced MTCT of HN by 67% in women who did
not breast-feed. Widespread implementation of this regimen in
the USA' and other countries including France' has led to a
marked reduction in the incidence of paediatric AIDS - a
public health triumph.
In March of this year the results of the first trial of a shorter
course of ZDV, designed to test the efficacy of a regimen that
might be implementable in parts of the developing world, were
reported.; A 4-week course of ZDV giyen orally in late
pregnancy and in labour to women in Thailand who did not
breast-feed showed that MTCT was reduced by 51 % (95%
confidence interval 15 - 71%). We were both invited to
participate in a meeting called by the Joint United ations
Programme on HN/ AIDS AIDS) to consider how these
results should be used to plan for programme implementation
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'The cost per HIV infection prevented was about R4 500 ... not a
bad way of spending money.'
of interventions to reduce MTCT of HIV. Is South Africa ready
- and willing - to reduce the number of children who are
infected with HIV by their mother?
UNAIDS estimated that globally in 1997, 1.1 million children
were liVing with HIV, 590000 newly infected.' The Department
of Health has used data from the national anonymous antenatal
surveys to estimate that 58000 babies were born with HIV
infection in South Africa in 1996.- KwaZulu- atal is the most
heavily affected province. We have estimated that in Hlabisa -
a health district typical of KwaZulu-Natal- 657 new
paediatric HIV infections occurred in 1997.8 What can be done
to red uce this burden?
HIV is transmitted from mother to child in three distinct
phases: antepartum (about 5%), intrapartum (15%) and
postpartum (10%), assuming an average 30% MTCT
transmission rate. If HN-infected women can safely avoid
breast-feeding they should, and this will reduce the risk of
MTCT by about one-third.' In Soweto MTCT was much lower
in women who chose to formula-feed (25%) than in those who
chose to breast-feed (42%), without any increased morbidity or
mortality attributable to formula-feeding (Glenda Gray -
personal communication). Women who can formula-feed
should also be offered a short course of mv, and this will
further reduce their risk by about one-half.' Unfortunately, we
do not yet know the efficacy of short-course ZDV in women
who have no choice but to breast-feed. Benefit in this group
will almost certainly be smaller than in the formula-feeding
group because ZDV use will create a larger cohort of
uninfected, and therefore susceptible, babies who will
subsequently be exposed to HN through breast-milk. The
(perhaps unlikely) worst-case scenario is that almost all the
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... simply going ahead now
and providing ZDV in those
sites that can already deliver
it would merely perpetuate.
existing inequities ...
benefit conferred by ZDV will be reversed by breast-feeding.
Following release of the Thai trial the manufacturers of ZDV,
Glaxo WelIcome, announced a cut in the international price of
the drug by 75%. This is equivalent to a 50% or so reduction in
the South African price to around R390 per woman, although
the price details are under negotiation.
Projections of the cost-effectiveness and affordability of
resources needed to implement an effective programme to
reduce MTCT in Hlabisa have been made by a group of
researchers working through the Hlabisa-Liverpool HIV LinkS
Short-course ZDV plus selective avoidance of breast-feeding is
likely to be a cost-effective intervention. Our best-case
projection was that up to 37% of paediatric HIV infections in
the district might be averted, at a total cost of around R1.2
million, equivalent to approximately 5% of the total district
health budget. The cost per paediatric HIV
infection prevented was about R4 500,
equivalent to R290 per discounted year of
life gained. In comparison with other
(established) public health interventions
such as childhood immunisation, cost-
effectiveness is similar. Put simply, this
would not be a bad way of spending
money. However, three other questions
need to be asked before doing so:
• are there better ways of spending it?
• is the money there to be spent?
• do we have the skills and resources to spend it?
Simplistically, the answers are 'yes', 'no' and 'perhaps'. Yes,
more cost-effective ways of preventing HIV infection do exist:
cost per disability-adjusted life-year (DALY) saved from
improved sexually transmitted disease syndromic management
is estimated at $10 (R45).1O With the substantial over-spend by
provincial health departments" in the last financial year, money
clearly is not available within current budgets for new,
expensive interventions. Could political pressure ensure that
new money is provided? Will South African women - and
men - apply this political pressure? In the Hlabisa best-case
projection, about R150 would need to be spen~per woman
screened. As approximately 1.4 million women become
pregnant each year in South Africa,' the government would
need to find at least an extra R210 million to fund a national
programme.
Even if the money is made available, serious questions must
be raised about how effectively such a national programme
could be implemented. Existing staff would need to be trained
in HIV counselling and midwifery skills, new staff would need
to be recruited, health facilities would need upgrading to
accommodate the increased numbers delivering under health
worker supervision, and HIV testing would need to be done
on-site in many antenatal clinics. one of these steps would be
quick or easy.
The 1997 South Africa Health Review ll reveals that the
country's health services are undergoing a painful process of
transition. Little is known about the status of reproductive
health services in the country, but it is probably quite patchy:
comprehensive maternal and child health services are said to
exist in between 13% and 80% of clinics in the different
provinces. Indications from some surveys are that a high
proportion of pregnant women attend antenatal services for at
least one visit, but that fewer deliver in a health service.",!'
Postnatal visits are considerably less frequent. I ' An assessment
of reproductive health services across the country, conducted in
1994 by the Reproductive Health Task Force, South African
Ministry of Health, and the Human Reproduction Programme
(HRP) of the World Health Organisation, Geneva, highlighted
the need to improve service quality as well as access to
services.
What is the way forward? We propose a
three-stage parallel process. The first
would be a process of national
consultation and consensus building that
aims to develop policy around a national
programme for the reduction of MTCT 9f
HIV. This might include provision of
antiretroviral drugs, provision of formula
feeds, development of training packages,
setting standards for HIV counselling and
testing, and so on. The second stage
would be the establishment of several implementation sites
representative of different settings throughout the country, so
that we can 'learn by doing'. These pilot sites would be given
the task of developing a programme to offer HIV counselling
and testing to pregnant women, to provide short-course ZDV
to HIV-infected women who want it, and to offer alternatives
to breast-feeding to those women who are considered able to
formula-feed safely. The sites would document the obstacles to
programme implementation and would develop strategies to
overcome these obstacles. Potential sites include those involved
in trials of perinatal antiretroviral drugs, including Durban and
Soweto. Rural sites such as Hlabisa or its neighbouring districts
could also be included, making use of the resources of the
Africa Centre for Population Studies and Reproductive Health..
The third stage would be ongoing research to develop effective
antiviral regimens that would allow breast-feeding to continue,
and its documented benefits to be maintained, or to test safe
modifications of breast-feeding, such as early weaning.
It is clear that any national programme ",ill fail without the
concurrent strengthenirg of South Africa's primary health care
.system. Indeed, simply going ahead now and providing mv
in those sites that can already deliver it would merely
perpetuate existing inequities - inequities between public and
private sectors, urban and rural areas and areas with different
resource level~, racial inequities, and so on. The HIV/ AIDS
epidemic is the greatest threat to this country's public health,
and with up to one-third of the young adult population
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infected in some parts of the country, it threatens the very
fabric of South African society. There is now a very real
opportunity to start implementing an intervention that will
reduce the number of children infected with I-llY. Done
properly, this implementation could also be used to strengthen
the health system itself.
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CLINICAL PRACTICE
A CHOLERA OUTBREAK AND
CONTROL IN A RURAL REGION OF
SOUTH AFRICA
Eugene Athan, Steven Donohue, David Durrheim
The outbreak of cholera that occurred in the Mpumalanga
lowveld early in 1998 highlights important lessons for cholera
management and control in South Africa. Vibrio cholerae 01, El
Tor biotype causes epidemic, life-threatening diarrhoea
worldwide, with a high proportion of asymptomatic cases and
carriers compared with the Classic biotype.' Currently
Mozambique is experiencing a large El Tor epidemic that was
confirmed in Maputo during August 1997, and totalled in
excess of 10 000 cases by the end of 1997.
Mpumalanga's lowveld region is a predominantly rural area
of South Africa, bordering Mozambique and Swaziland, and
many Mozambican economic migrants are recruited here as.
casual labour on banana and sugar plantations.
A young Mozambican man was the index case of a localised
outbreak in Shongwe district. He arrived from Maputo on
23 February 1998, and found casual employment on a banana
plantation situated on the northern bank of the Lomati River.
He developed profuse watery diarrhoea on the night of arrival,
and was discovered shocked and partially submerged in the
river the following morning. After he had been resuscitated at
Shongwe Hospital, V. cholerae 01, El Tor, Ogawa strain was
cultured from his stool.
Phiva village (population 8 000) is located on the opposite
bank of the Lomati. Water for treatment and supply to village
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